Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized trial of Lianhua Yuping Granules for common cold with qi deficiency syndrome
ChiCTR2500106925Phase 2Not yet recruiting
- Sponsor
- Guang'anmen Hospital
- Start
- Jul 2025
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Lianhua Yuping granules in nasopharyngitis (3 arms), sponsored by Guang'anmen Hospital. Primary endpoints: Proportion of subjects with disappearance or improvement of each individual common cold symptom, Proportion of subjects with disappearance or improvement of each individual qi deficiency symptom and 4 more. Planned start Jul 2025; status: not yet recruiting.
02
Drugs
Lianhua Yuping granules
03
Conditions
nasopharyngitis
Beyond the preview
Go deeper on ChiCTR2500106925.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500106925.